| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.29 | 6e-14 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.28 | 4e-12 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.25 | 5e-11 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.29 | 9e-10 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.24 | 2e-09 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.23 | 7e-09 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-08 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.22 | 1e-08 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.21 | 2e-08 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.35 | 2e-08 |